Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavana Pothuri

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
Antibody-Drug Conjugates in Gynecologic CancerHannah C Karpel, Sachia Stonefeld Powell, Bhavana Pothuri
Gynecologic Oncology|August 12, 2020
Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statementBhavana Pothuri, Roisin O'Cearbhaill, Ramez Eskander, et al.
Gynecologic Oncology Reports|July 14, 2021
Medical marijuana utilization in gynecologic cancer patientsJulia Fehniger, Allison L Brodsky, Arum Kim, et al.
Current Opinion in Obstetrics & Gynecology|November 29, 2024
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025Tarik Silk, Kari E Hacker, Whitfield Growdon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Biomarker-driven therapy in endometrial cancerHannah Karpel, Brian Slomovitz, Robert L Coleman, et al.
Gynecologic Oncology Reports|September 19, 2024
Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancyOlivia D Lara, Kathryn Allen, Amin Yakubov, et al.
Gynecologic Oncology|June 8, 2023
Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancerHannah C Karpel, Maria Smith, Allison Brodsky, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
PARP inhibition as frontline therapy in ovarian cancerKathleen N Moore, Bhavana Pothuri, Bradley Monk, et al.
Current Opinion in Obstetrics & Gynecology|March 21, 2023
Treatment options for molecular subtypes of endometrial cancer in 2023Hannah C Karpel, Brian Slomovitz, Robert L Coleman, et al.
Gynecologic Oncology|August 6, 2025
HER2 expression in an endometrial cancer cohortKari E Hacker, Kathryn A Fleming, Mamta Gupta, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 25, 2023
Antibody-Drug Conjugates in Gynecologic CancerHannah C Karpel, Sachia Stonefeld Powell, Bhavana Pothuri
Gynecologic Oncology|August 12, 2020
Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statementBhavana Pothuri, Roisin O'Cearbhaill, Ramez Eskander, et al.
Gynecologic Oncology Reports|July 14, 2021
Medical marijuana utilization in gynecologic cancer patientsJulia Fehniger, Allison L Brodsky, Arum Kim, et al.
Current Opinion in Obstetrics & Gynecology|November 29, 2024
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025Tarik Silk, Kari E Hacker, Whitfield Growdon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Biomarker-driven therapy in endometrial cancerHannah Karpel, Brian Slomovitz, Robert L Coleman, et al.
Gynecologic Oncology Reports|September 19, 2024
Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancyOlivia D Lara, Kathryn Allen, Amin Yakubov, et al.
Gynecologic Oncology|June 8, 2023
Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancerHannah C Karpel, Maria Smith, Allison Brodsky, et al.
Clinical Advances in Hematology & Oncology : H&O|October 2, 2020
PARP inhibition as frontline therapy in ovarian cancerKathleen N Moore, Bhavana Pothuri, Bradley Monk, et al.
Current Opinion in Obstetrics & Gynecology|March 21, 2023
Treatment options for molecular subtypes of endometrial cancer in 2023Hannah C Karpel, Brian Slomovitz, Robert L Coleman, et al.
Gynecologic Oncology|August 6, 2025
HER2 expression in an endometrial cancer cohortKari E Hacker, Kathryn A Fleming, Mamta Gupta, et al.
Pageof 14